Search | Page 10 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Higher-risk myelodysplastic syndromes with del(5q): is sequential azacitidine-lenalidomide combination the way to go?

    ... and lenalidomide in del(5q) higher-risk myelodysplastic syndromes or acute myeloid leukemia: a Phase I study. Leukemia ...

    Research Article last updated 07/20/2018 - 5:15pm.

  2. Standardizing the Initial Evaluation for Myelodysplastic Syndromes.

    ... The myelodysplastic syndromes (MDS) pose a unique diagnostic challenge for clinicians and ...

    Research Article last updated 07/20/2018 - 5:15pm.

  3. Effectiveness and safety of different azacitidine dosage regimens in patients with myelodysplastic syndromes or acute myeloid leukemia

    ... in patients with World Health Organization-defined myelodysplastic syndromes , or acute myeloid leukemia with 20-30% bone marrow ...

    Research Article last updated 07/20/2018 - 5:15pm.

  4. Myelodysplastic syndromes: toward a risk-adapted treatment approach.

    ... and scoring systems have been developed in myelodysplastic syndromes (MDS to predict the risk of progression to acute myeloid leukemia ...

    Research Article last updated 07/20/2018 - 5:15pm.

  5. Myelodysplastic syndromes.

    ... have been achieved in understanding and treating myelodysplastic syndromes (MDS) in the past decade. For the first time, three drugs were ...

    Research Article last updated 07/20/2018 - 5:15pm.

  6. Risk of acute leukemia and myelodysplastic syndromes in patients with monoclonal gammopathy of undetermined significance (MGUS): a population-based study of 17 315 patients

    ... if there is an increased risk of acute leukemia and myelodysplastic syndromes (MDS) in persons with monoclonal gammopathy of undetermined ...

    Research Article last updated 07/20/2018 - 5:15pm.

  7. Azacitidine in lower-risk myelodysplastic syndromes.

    ... conventional care regimens in patients with higher-risk myelodysplastic syndromes (MDS). Here, we review currently available data on azacitidine ...

    Research Article last updated 07/20/2018 - 5:14pm.

  8. Current and future management options for myelodysplastic syndromes.

    ... The management of the myelodysplastic syndromes (MDS) requires insight into the complex biology of the disease. ...

    Research Article last updated 07/20/2018 - 5:14pm.

  9. Molecular Pathophysiology of Myelodysplastic Syndromes.

    ... The clinicopathologic heterogeneity of myelodysplastic syndromes (MDS) is driven by diverse, somatically acquired genetic ...

    Research Article last updated 07/20/2018 - 5:14pm.

  10. Epidemiology of myelodysplastic syndromes

    ... Myelodysplastic syndromes (MDS) comprise a heterogeneous group of clonal hematopoietic stem ...

    Research Article last updated 07/20/2018 - 5:14pm.